Financials Cutera, Inc.

Equities

CUTR

US2321091082

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 04:00:00 2024-04-26 pm EDT 5-day change 1st Jan Change
2.12 USD +3.92% Intraday chart for Cutera, Inc. +8.72% -39.86%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Capitalization 1 236.6 509.7 425.1 742 867.4 42.32 42.32 -
Enterprise Value (EV) 1 201.1 475.8 385.3 742 867.4 70.55 42.32 42.32
P/E ratio -7.63 x -40.7 x -16.9 x 376 x -10.1 x -0.46 x -0.39 x -0.46 x
Yield - - - - - - - -
Capitalization / Revenue 1.45 x 2.8 x 2.88 x 3.21 x 3.44 x 0.33 x 0.26 x 0.24 x
EV / Revenue 1.45 x 2.8 x 2.88 x 3.21 x 3.44 x 0.33 x 0.26 x 0.24 x
EV / EBITDA 74.2 x 87.8 x -72.7 x 35.8 x -121 x -0.82 x -0.67 x -0.97 x
EV / FCF -200,375,233 x -158,884,394 x -23,341,741 x - -9,670,726 x - - -
FCF Yield -0% -0% -0% - -0% - - -
Price to Book - - - - - - - -
Nbr of stocks (in thousands) 13,904 14,233 17,633 17,957 19,615 19,961 19,961 -
Reference price 2 17.02 35.81 24.11 41.32 44.22 2.120 2.120 2.120
Announcement Date 2/20/19 2/26/20 2/17/21 2/22/22 2/28/23 3/21/24 - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Net sales 1 162.7 181.7 147.7 231.3 252.4 212.4 163.2 178
EBITDA 1 3.188 5.807 -5.845 20.74 -7.15 -85.65 -63.45 -43.85
EBIT 1 -13.39 -12.06 -22.83 1.83 -38.19 -143 -126.9 -78.8
Operating Margin -8.23% -6.64% -15.46% 0.79% -15.13% -67.35% -77.7% -44.26%
Earnings before Tax (EBT) 1 -13.52 -12.26 -23.41 3.385 -80.7 -149.3 -131.7 -82.14
Net income 1 -30.77 -12.35 -23.88 2.062 -82.34 -150.8 -130.8 -86.59
Net margin -18.91% -6.8% -16.17% 0.89% -32.62% -71.02% -80.14% -48.63%
EPS 2 -2.230 -0.8800 -1.430 0.1100 -4.390 -7.590 -5.443 -4.623
Free Cash Flow -1.181 -3.208 -18.21 - -89.69 - - -
FCF margin -0.73% -1.77% -12.33% - -35.54% - - -
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share 2 - - - - - - - -
Announcement Date 2/20/19 2/26/20 2/17/21 2/22/22 2/28/23 3/21/24 - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 58.59 57.38 65.63 58.01 64.22 62.81 67.35 54.99 61.22 46.48 49.54 37.66 40.01 39.96 45.62
EBITDA 1 6.78 5.077 4.309 -3.805 -1.636 -1.951 0.242 -14.5 -11.6 -28.75 -26.11 -15.8 -12.45 -16.85 -18.3
EBIT 1 2.068 0.626 -2.029 -13.16 -10.06 -9.433 -5.536 -23.57 -29.53 -40.95 -44.32 -30.85 -29.91 -32.09 -34
Operating Margin 3.53% 1.09% -3.09% -22.68% -15.67% -15.02% -8.22% -42.86% -48.24% -88.1% -89.45% -81.92% -74.77% -80.31% -74.52%
Earnings before Tax (EBT) 1 7.868 -0.928 -3.454 -14.91 -47.46 -11.31 -7.024 -24.74 -31.32 -44.11 -44.46 -32.04 -31.13 -33.31 -35.22
Net income 1 7.746 -1.39 -3.935 -15.14 -47.28 -12.13 -7.788 -25.02 -31.64 -44.27 -45.23 -31.82 -30.91 -33.09 -35
Net margin 13.22% -2.42% -6% -26.1% -73.61% -19.32% -11.56% -45.49% -51.69% -95.26% -91.3% -84.5% -77.27% -82.83% -76.7%
EPS 2 0.3900 -0.0800 -0.2200 -0.8400 -2.530 -0.6200 -0.4000 -1.260 -1.590 -2.220 -2.270 -1.347 -1.203 -1.417 -1.477
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 8/4/21 11/3/21 2/22/22 5/10/22 8/4/22 11/3/22 2/28/23 5/9/23 8/8/23 3/5/24 3/21/24 - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Net Debt - - - - - - - -
Net Cash position 35.6 33.9 39.9 - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow -1.18 -3.21 -18.2 - -89.7 - - -
ROE (net income / shareholders' equity) -55.3% -26.8% -46.4% - - - - -
ROA (Net income/ Total Assets) -29.5% -11.7% -19.4% - - - - -
Assets 1 104.4 105.7 123.2 - - - - -
Book Value Per Share - - - - - - - -
Cash Flow per Share - - - - - - - -
Capex 1.49 0.99 1.28 1.02 22.7 - - -
Capex / Sales 0.91% 0.55% 0.87% 0.44% 8.99% - - -
Announcement Date 2/20/19 2/26/20 2/17/21 2/22/22 2/28/23 3/21/24 - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
2.12 USD
Average target price
6.333 USD
Spread / Average Target
+198.74%
Consensus
  1. Stock Market
  2. Equities
  3. CUTR Stock
  4. Financials Cutera, Inc.